Mark Spielman is a seasoned professional in the cardiology sales field, currently serving as a Senior Cardiology Account Manager at Abiomed since 2013. Prior to this role, Mark held positions at Bayer Interventional from August 2005 to April 2013, focusing on the sale of advanced medical systems to healthcare professionals across New York. Mark's responsibilities included managing a $4.6 million territory and training physicians on product use. Earlier experience includes work as a Critical Care Specialist at The Medicines Company, where Mark effectively promoted Angiomax and established strong relationships within Cardiac Cath Labs. Mark holds a Bachelor of Science degree in Health Science from the State University of New York Cortland.